{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:01:01Z","timestamp":1791021661654,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1124\/jpet.110.171090","type":"journal-article","created":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T01:46:54Z","timestamp":1280454414000},"page":"324-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Peroxisome Proliferator-Activated Receptor \u03b1 Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats"],"prefix":"10.1016","volume":"335","author":[{"given":"Paolo","family":"Gelosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Gianella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Brioschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Pignieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.171090_bib1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.ajkd.2004.11.004","article-title":"Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS)","volume":"45","author":"Ansquer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.110.171090_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1160\/TH03-01-0059","article-title":"Induction of plasminogen activator inhibitor I by the PPAR\u03b1 ligand,Wy-14,643, is dependent on ERK1\/2 signaling pathway","volume":"90","author":"Banfi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1124\/jpet.110.171090_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ejheart.2008.01.016","article-title":"Oxidized proteins in plasma of patients with heart failure: role in endothelial damage","volume":"10","author":"Banfi","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1124\/jpet.110.171090_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2005.06.019","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor \u03b1 agonist, exerts neuroprotective effects in traumatic brain injury","volume":"388","author":"Besson","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.110.171090_bib5","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.STR.29.8.1671","article-title":"Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats","volume":"29","author":"Blezer","year":"1998","journal-title":"Stroke"},{"key":"10.1124\/jpet.110.171090_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1042\/BST0341341","article-title":"PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases","volume":"34","author":"Bordet","year":"2006","journal-title":"Biochem Soc Trans"},{"key":"10.1124\/jpet.110.171090_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.110.171090_bib8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1046\/j.1471-4159.1997.68062451.x","article-title":"Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer\u2019s disease","volume":"68","author":"Butterfield","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/jpet.110.171090_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.freeradbiomed.2006.04.030","article-title":"Oxidative stress and inflammatory response evoked by transient cerebral ischemia\/reperfusion: effects of the PPAR-\u03b1 agonist WY14643","volume":"41","author":"Collino","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.110.171090_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1471-4914(03)00031-5","article-title":"Protein carbonylation in human diseases","volume":"9","author":"Dalle-Donne","year":"2003","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.110.171090_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1690453","article-title":"Peroxisome proliferator-activated receptors in inflammation control","volume":"169","author":"Delerive","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.110.171090_bib12","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1523\/JNEUROSCI.23-15-06264.2003","article-title":"Peroxisome proliferator-activated receptor-\u03b1 activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment","volume":"23","author":"Deplanque","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.110.171090_bib13","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/HJH.0b013e3283311ba1","article-title":"Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage","volume":"27","author":"Gelosa","year":"2009","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.110.171090_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2353\/ajpath.2007.060882","article-title":"Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats","volume":"170","author":"Gianella","year":"2007","journal-title":"Am J Pathol"},{"issue":"Suppl","key":"10.1124\/jpet.110.171090_bib15","first-page":"S47","article-title":"Antioxidants and protein oxidation","volume":"33","author":"Griffiths","year":"2000","journal-title":"Free Radic Res"},{"key":"10.1124\/jpet.110.171090_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/hs0302.104111","article-title":"New insights into brain damage in stroke-prone rats: a nuclear magnetic imaging study","volume":"33","author":"Guerrini","year":"2002","journal-title":"Stroke"},{"key":"10.1124\/jpet.110.171090_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2008.04.025","article-title":"Rosiglitazone, a PPAR \u03b3 agonist, attenuates inflammation after surgical brain injury in rodents","volume":"1215","author":"Hyong","year":"2008","journal-title":"Brain Res"},{"key":"10.1124\/jpet.110.171090_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2003.09.001","article-title":"Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor \u03b1 in mice","volume":"352","author":"Inoue","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.110.171090_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/hr.2008.27","article-title":"Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk","volume":"32","author":"Ito","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1124\/jpet.110.171090_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1042\/bj20031207","article-title":"Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor \u03b3 (PPAR\u03b3), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo","volume":"377","author":"Jiang","year":"2004","journal-title":"Biochem J"},{"key":"10.1124\/jpet.110.171090_bib21","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"key":"10.1124\/jpet.110.171090_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2215\/CJN.04341206","article-title":"Stroke and its prevention in chronic kidney disease","volume":"2","author":"Khella","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.110.171090_bib23","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1182\/blood.V93.9.2991.409k03_2991_2998","article-title":"Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-\u03b1","volume":"93","author":"Kockx","year":"1999","journal-title":"Blood"},{"key":"10.1124\/jpet.110.171090_bib24","first-page":"7","article-title":"Inflammatory mechanisms in ischemic stroke: therapeutic approaches","volume":"17","author":"Lakhan","year":"2009","journal-title":"J Transl Med"},{"key":"10.1124\/jpet.110.171090_bib25","first-page":"345","article-title":"Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb","volume":"36","author":"Madej","year":"1998","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.110.171090_bib26","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1161\/01.CIR.99.24.3125","article-title":"PPAR\u03b1 activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells","volume":"99","author":"Marx","year":"1999","journal-title":"Circulation"},{"key":"10.1124\/jpet.110.171090_bib27","doi-asserted-by":"crossref","first-page":"H1899","DOI":"10.1152\/ajpheart.01014.2005","article-title":"Effects of chronic activation of peroxisome proliferator-activated receptor-\u03b1 or high-fat feeding in a rat infarct model of heart failure","volume":"290","author":"Morgan","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.110.171090_bib28","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.jcbfm.9591524.0056","article-title":"Acute treatment by a PPAR-\u03b1 agonist decreases cerebral infarct volume and prevents post-ischemic endothelium and Kir 2.1 impairment","volume":"25","author":"Ouk","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1124\/jpet.110.171090_bib29","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0891-5849(99)00144-6","article-title":"Oxidized proteins as a marker of oxidative stress during coronary heart surgery","volume":"27","author":"Pantke","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.110.171090_bib30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1592\/phco.23.15.1611.31962","article-title":"A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension","volume":"23","author":"Park","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1124\/jpet.110.171090_bib31","doi-asserted-by":"crossref","first-page":"32833","DOI":"10.1074\/jbc.273.49.32833","article-title":"Peroxisome proliferator-activated receptor \u03b1 activation modulates cellular redox status, represses nuclear factor-\u03baB signaling, and reduces inflammatory cytokine production in aging","volume":"273","author":"Poynter","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.171090_bib32","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0022-2275(20)37269-2","article-title":"Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product","volume":"38","author":"Siems","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1124\/jpet.110.171090_bib33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.104.072066","article-title":"Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall","volume":"311","author":"Sironi","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.171090_bib34","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.ATV.0000157145.98200.55","article-title":"Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects","volume":"25","author":"Sironi","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/jpet.110.171090_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.STR.32.3.753","article-title":"Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics","volume":"32","author":"Sironi","year":"2001","journal-title":"Stroke"},{"key":"10.1124\/jpet.110.171090_bib36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPAR\u03b1 but not by PPAR\u03b3 activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"10.1124\/jpet.110.171090_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.neuroscience.2004.10.021","article-title":"Peroxisome proliferator-activated receptor-\u03b3 ligands reduce inflammation and infarction size in transient focal ischemia","volume":"130","author":"Sundararajan","year":"2005","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.110.171090_bib38","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2215\/CJN.03260807","article-title":"Stroke in chronic kidney disease: prevention and management","volume":"3 (Suppl 1)","author":"Townsend","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/jpet.110.171090_bib39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ki.1996.186","article-title":"Advanced oxidation protein products as a novel marker of oxidative stress in uremia","volume":"49","author":"Witko-Sarsat","year":"1996","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.110.171090_bib40","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1523\/JNEUROSCI.5857-08.2009","article-title":"Neuronal PPAR\u03b3 deficiency increases susceptibility to brain damage after cerebral ischemia","volume":"29","author":"Zhao","year":"2009","journal-title":"J Neurosci"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524460874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524460874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.171090","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:20:21Z","timestamp":1740018021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524460874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0022356524460874"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.171090","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peroxisome Proliferator-Activated Receptor \u03b1 Agonism Prevents Renal Damage and the Oxidative Stress and Inflammatory Processes Affecting the Brains of Stroke-Prone Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.171090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}